Paper Details

  1. Home
  2. Paper Details

[Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].

Author: AkitaH, IwataS, SatoY, SunakawaK

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Cefpodoxime proxetil (CPDX-PR), a new oral cephem, was effective in treating various pediatric infections. The efficacy rate was 91.8%, and side effects were mild.
Paper Details　
Original Abstract of the Article :
Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil (CPDX-PR, CS-807), a newly developed oral cephem, were carried out in the treatment of infectious diseases in the field of pediatrics. 1. Since CPDX demonstrates very powerful antimicrobial actions against such Gram-negati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2810729

データ提供：米国国立医学図書館（NLM）

Cefpodoxime Proxetil: A New Hope for Pediatric Infections

The fight against infections in children is a constant battle. This research investigates the efficacy and safety of cefpodoxime proxetil (CPDX-PR) in treating infectious diseases in children. The researchers conducted pharmacokinetic, bacteriological, and clinical studies to evaluate the drug's effectiveness against a wide range of bacterial infections. The study aims to establish the potential of CPDX-PR as a safe and effective treatment option for pediatric infections.

Cefpodoxime Proxetil: A Beacon in the Desert of Illness

The study reveals that CPDX-PR demonstrates potent antimicrobial activity against various bacteria commonly associated with pediatric infections. Like a camel finding a lush oasis after a long journey, CPDX-PR offers a promising solution for children battling infections. The research shows that CPDX-PR effectively treats a wide range of infections, including upper respiratory tract infections, bronchitis, pneumonia, otitis media, and urinary tract infections.

A Safe and Effective Treatment Option

The research indicates that CPDX-PR is a safe and effective treatment option for pediatric infections. Like a trusted guide leading a caravan through a challenging desert, CPDX-PR provides a reliable path to recovery for young patients. The study reveals a high efficacy rate and a low incidence of adverse effects, making CPDX-PR a valuable asset in the fight against pediatric infections.

Dr. Camel's Conclusion

This research highlights the potential of cefpodoxime proxetil as a safe and effective treatment option for pediatric infections. By understanding the efficacy and safety profile of this drug, healthcare professionals can confidently treat children with a wide range of infections, offering them a chance for a speedy recovery and a return to their playful adventures.

Date :
  1. Date Completed 1989-12-04
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

2810729

DOI: Digital Object Identifier

2810729

Related Literature

Article Analysis
・Side Effects of cefpodoxime
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.